PFF issues warning about non-prescription supplemental oxygen
By HME News Staff
Updated 9:30 AM CDT, Tue May 9, 2023
CHICAGO – The medical advisory board of the Pulmonary Fibrosis Foundation (PFF) has issued a position statement on non-prescription supplemental oxygen that advises the patient community to use only devices approved by the U.S. Food and Drug Administration as prescribed by their doctor. The PFF warns that patients should not purchase an oxygen supply device without a prescription from a health care provider because doing so may lead to serious health problems. It also warns non-FDA approved oxygen delivery systems may not reliably deliver oxygen. "Supplemental oxygen therapy is necessary and beneficial to many people living with PF,” said Dr. Amy Hajari Case, senior medical advisor for education and awareness for the PFF. “Oxygen users often prefer portable oxygen concentrators (POC) so they can remain active and mobile. Unfortunately, existing POCs have limitations such as short battery life and inadequate oxygen flow. However, non-FDA approved portable oxygen concentrators available online are not the solution. Patients should always speak with their health care provider before any out-of-pocket purchase of a portable oxygen concentrator." In February, the PFF joined with 23 other patient, professional and industry groups to advocate for patient-centric legislative changes to supplemental oxygen supply and reimbursement. The PFF's efforts to advocate for improvements in access to oxygen are ongoing. To review the full statement, click here.
Comments